Laura Niklason
Fortune : 909 035 $ au 31/07/2026
Fortune : 909 035 $ au 31/07/2026
Laura E.
Niklason is the founder of Humacyte Global, Inc., founded in 2004, serving as President, Chief Executive Officer & Director.
Dr. Niklason is the founder of Humacyte, Inc., founded in 2004, serving as President, Chief Executive Officer & Director.
Current jobs include Director at Learnswell Inc, Director at Self Study, Inc., and Advisory Board member at BioVentures Investors.
Former job includes Professor at Yale University from 2006 to 2020.
Education includes a doctorate from The University of Chicago, a doctorate from the University of Michigan, and an undergraduate degree from the University of Illinois At Urbana–Champaign.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
HUMACYTE, INC. 0,52 % | 11/06/2026 | 1 392 091 ( 0,52 % ) | 909 035 $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| HUMACYTE, INC. | Fondateur | 13/10/2004 |
Humacyte Global, Inc.
Humacyte Global, Inc. Medical SpecialtiesHealth Technology Develops human tissue-based investigational products | Fondateur | 01/01/2004 |
Learnswell Inc
Learnswell Inc Miscellaneous Commercial ServicesCommercial Services Operates learning center | Directeur/Membre du Conseil | - |
BioVentures Investors
BioVentures Investors Investment ManagersFinance BioVentures invests in companies located in the United States. The firm focuses on the health care and medtech sectors. It provides financing for seed, early and growth stage capital requirements with an investment size of USD 5 - 25 million. It also takes a seat on the board of directors. | Consultant / Advisor | - |
| Sociétés | Poste | Fin |
|---|---|---|
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/11/2020 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 8 |
|---|---|
Humacyte Global, Inc.
Humacyte Global, Inc. Medical SpecialtiesHealth Technology Develops human tissue-based investigational products | Health Technology |
The University of Chicago
The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioVentures Investors
BioVentures Investors Investment ManagersFinance BioVentures invests in companies located in the United States. The firm focuses on the health care and medtech sectors. It provides financing for seed, early and growth stage capital requirements with an investment size of USD 5 - 25 million. It also takes a seat on the board of directors. | Finance |
University of Illinois At Urbana–Champaign
University of Illinois At Urbana–Champaign Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Learnswell Inc
Learnswell Inc Miscellaneous Commercial ServicesCommercial Services Operates learning center | Commercial Services |
Humacyte, Inc.
Humacyte, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national